Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.

Inclusion Criteria:

• Adults aged 19 years or older
• Diagnosed with early or advanced gastric, lung, breast, or colon cancer
• Starting first-cycle chemotherapy with a new anticancer agent
• Able to use a smartphone without difficulty
• Willing to provide informed consent to participate in the study

Exclusion Criteria:

• Individuals who have difficulty communicating due to cognitive impairment, visual impairment, hearing impairment, or other reasons
• Individuals who cannot read, write, or understand Korean
• Other individuals deemed inappropriate for participation by the investigators